Dublin, Jan. 10, 2018 -- The "Adult Incontinence Nonwovens Outlook" report has been added to Research and Markets' offering.
The market of incontinence nonwovens is currently estimated to be worth around US6.5 billion and is predicted to almost double in value by 2020.
The sector growth is driven by ageing population. It is expected that the global population of over 60s will increase by 56% to 1.4 billion people by 2050. Moreover, technological developments will facilitate the market development.
This report aims to provide an overview of the market size as well as the demographic factors driving demand for incontinence products. It also covers the economics of incontinence products. It focuses on incontinence in older age groups rather than those affecting children and adults under the age of 60.
In addition, the report presents key market opportunities players should be exploiting in the incontinence sector; some of which include taking advantage of the direct-to-consumer market online, and providing incontinence as part of a one-stop shop' approach to long-term care.
Key Topics Covered:
1. Executive Summary
2. Market size
2.1 Size of ageing population by region over time
2.2 Size of the market for incontinence products
2.2.1 Types of incontinence
2.3 Risk factors
3. Economics of incontinence products
3.1 Cost of long-term care
3.2 Spend on incontinence products
3.3 Supply chain
3.3.1 Supply to healthcare providers
3.3.2 Supply direct to end-user
3.4 Influences on the market
Companies Mentioned
- BSN Medical
- Confitex
- EDANA
- Essity
- Fater
- National Association of Continence
- Procter & Gamble
- SCA
- World Health Organisation
For more information about this report visit https://www.researchandmarkets.com/research/jvqdfc/global_adult?w=12
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Personal Care Products , Technical Textiles


Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Washington Post Publisher Will Lewis Steps Down After Layoffs
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances 



